CPHI Americas will relocate to Miami for its 2027 show.
Event organiser Informa Markets said the move was intended to enhance international accessibility, increase executive participation and support the event's growth as a key platform for pharmaceutical innovation and partnerships.
It added that the move reflected CPHI Americas' commitment to creating a more connected, content-driven experience for the global pharma community, citing Miami's position as a major international gateway as providing larger opportunities for networking, collaboration and business development.
Miami's extensive international flight network also made it a strong candidate for the move, offering direct connections to major markets across Europe and beyond.
"CPHI Americas has evolved significantly in recent years, with increasing demand for high-value content, executive networking and strategic business engagement," said Sherma Ellis-Daal, of Informa Markets.
Miami offers the international accessibility, business environment and hospitality infrastructure needed to support the next phase of the event's growth while delivering an exceptional experience for attendees, exhibitors and partners.
Informa Markets expects the enhanced accessibility to attract a more diverse international audience, creating new opportunities for collaboration across the pharmaceutical, biotechnology and healthcare sectors.
Visitors to the show will also have the following benefits:
- year-round warm weather
- beachfront accommodations and meeting spaces
- extensive hotel capacity
- a diverse restaurant and entertainment offering.
Miami also holds appeal among private equity firms, venture capital groups, healthcare investors and international business organisations, creating an environment that "extends beyond traditional conference networking."
Informa Markets said it expected this would support increased participation from pharmaceutical executives, investors and senior decision-makers.
The show will take place May 25-26, 2027, at the Miami Convention Centre